Amin Haiderali

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Chemotherapy Induced

Sentinel Lymph Node

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Amin Haiderali, Min Huang, Wilbur Pan, Katherine G Akers, Dylan Maciel, Andrew M Frederickson
Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer. Future oncology (London, England) (2024)
Amin Haiderali, Min Huang, Wilbur Pan, Katherine G Akers, Dylan Maciel, Andrew M Frederickson
Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer. Future oncology (London, England) (2024)
Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Wilbur Pan, Vassiliki Karantza, Fan Yang, James Truscott, Yiqiao Xin, Joyce O'Shaughnessy
Association between event-free survival and overall survival in early-stage triple-negative breast cancer. Future oncology (London, England) (2023)
Min Huang, Peter Fasching, Amin Haiderali, Wilbur Pan, Emma Gray, Zheng-Yi Zhou, Peter Hu, Mitashri Chaudhuri, Celine Le Bailly De Tilleghem, Nicolas Cappoen, Joyce O'Shaughnessy
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer. Immunotherapy 14 (13) (2022)
Amin Haiderali, Whitney C Rhodes, Santosh Gautam, Min Huang, Jan Sieluk, Karen E Skinner, Lee S Schwartzberg
Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer. Future oncology (London, England) 17 (29) (2021)
Amin Haiderali, Whitney C Rhodes, Santosh Gautam, Min Huang, Jan Sieluk, Karen E Skinner, Lee S Schwartzberg
Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer. Future oncology (London, England) 17 (29) (2021)